Trial no.:
|
PACTR202112652853611 |
Date of Approval:
|
22/12/2021 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Effect Of Serum HCG Levels And Follicular Fluid Fas Levels On ICSI Outcomes In Different Highly Purified HMG Stimulation Protocols |
Official scientific title |
consecutive or concomitant hp-hMG with FSH; milder response but higher quality |
Brief summary describing the background
and objectives of the trial
|
assess the effect of serum levels of human chorionic gonadotropin hormone (HCG) and follicular fluid soluble Fas levels on outcome of intra-cytoplasmic sperm injection (ICSI) cycles with two different human menopausal gonadotropins (HMG) stimulation protocols either consecutive or concomitant with FSH |
Type of trial |
CCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Obstetrics and Gynecology |
Sub-Disease(s) or condition(s) being studied |
Fertility-female |
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
01/04/2020 |
Actual trial start date |
13/04/2020 |
Anticipated date of last follow up |
20/06/2021 |
Actual Last follow-up date |
01/07/2021 |
Anticipated target sample size (number of participants) |
100 |
Actual target sample size (number of participants) |
100 |
Recruitment status |
Completed |
Publication URL |
|
|